Under an agreement with the Indiana University Research and Technology Corp., La Jolla Pharmaceutical Co. obtained an exclusive option to acquire intellectual property rights to “next-generation” offshoots of gentamicin. Gentamicin is part of a class of hospital-grade antibiotics known as aminoglycosides that are commonly used to treat staph, urinary tract, heart and pregnancy-related infections. Despite… Read more »
Tag: Life Sciences
Workshop to better understand proposals and submissions for NIH funding slated for May 27
“Writing/Designing Winning NIH Proposals,” a workshop to help participants better understand procedures for writing and submitting research funding proposals for the National Institutes for Health is scheduled for 8:30 a.m. to 4:30 p.m. on Wednesday, May 27, at the IUPUI Campus Center. Areas covered will include navigating the NIH website, improving proposal-writing skills and the… Read more »
Regenerative medicine symposium set for May 19-20 at The Athenaeum in downtown Indy
Researchers with an interest in regenerative medicine are invited to attend a two-day symposium May 19-20 titled “Regulatory Pathways for Regenerative Medicine: Cell and Biological Therapeutics.” The event will take place at The Athenaeum at 401 E. Michigan St. in Indianapolis. Didactic sessions, as well as abstract and poster sessions will run from 8:30 a.m…. Read more »
Regenstrief Institute wins special recognition for health tech at 16th annual Mira Awards
The Regenstrief Institute was recognized for “special contributions to health technology” Saturday during TechPoint’s 16th annual Mira Award ceremonies. The Institute was established by philanthropist Sam Regenstrief on the Indiana University Purdue University Indianapolis campus in 1969 and works closely with the IU School of Medicine and Wishard-Eskenazi Health. It is a internationally respected informatics… Read more »
Co-developers of Ebola drug ZMapp, IU-based treatment for PTSD among speakers at JCEB's first Innovation Conference at IU-Bloomington
The Johnson Center for Entrepreneurship in Biotechnology’s inaugural Innovation Conference at IU-Bloomington is scheduled for 12:30 p.m. to 6:30 p.m., April 24 in the Frangipani Room of the Indiana Memorial Union. It will feature speakers who cover topics related to commercializing academic research, including how to launch a business through IU’s Spin Up program. Additional topics… Read more »
IU-licensed drug for fragile X syndrome to be developed, marketed for Europe, Middle East
Indianapolis–based Confluence Pharmaceuticals Inc. and Vienna-based AOP Orphan Pharmaceuticals AG have reached an agreement to co-develop and market an Indiana University-licensed drug throughout Europe and the Middle East to combat the most commonly known genetic cause of autism. There are currently no approved treatments for the social and communicative impairments that accompany fragile X syndrome,… Read more »
Deadline of April 1 set for applications to Pilot Grant Program established by IU's Johnson Center for Entrepreneurship in Biotechnology
The Pilot Grant Program, offered by the Johnson Center for Entrepreneurship in Biotechnology at IU-Bloomington, funds “proof of concept” projects from any discipline that supports research projects that can: Be developed with an industry partner Serve as the basis to launch a new company Be used to strengthen patent applications based on IU-B discoveries. Project… Read more »
Legal issues in university technology transfer, biotech patents focus of Thursday symposium
Persons who want to learn more about legal issues that involve university technology transfers, the patenting process, clinical trials and similar issues can register to attend a Thursday, March 12 symposium at IU’s Robert H. McKinney School of Law on the campus of Indiana University Purdue University Indianapolis. The school’s Center for Intellectual Property Law… Read more »
IU startup Arrhythmotech to showcase its research at NIH innovation conference in Ohio
Arrhythmotech LLC, an Indiana University startup company that is developing a new generation of cardio monitoring instruments, has been selected to make a poster presentation of its work on Wednesday, March 4, during the National Heart, Lung and Blood Institute’s (NHLBI) Regional Innovation Conference-Midwest in Columbus, Ohio. NHLBI is a division of the National Institutes… Read more »
Indiana University well represented among nominees for the 16th annual Mira Awards
The nominees for TechPoint’s 16th annual Mira Awards have been announced and several have Indiana University ties. Presented by BKD CPAs & Advisors, these awards recognize the top companies and individuals involved in technology innovation statewide. The exposure and prestige offered by the Miras serves as a powerful springboard for Hoosier entrepreneurs. Past winners have… Read more »